| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 27,451,000 | 27,351,000 | 28,800,000 | 33,603,000 | | Cost of Revenue | 20,855,000 | 20,835,000 | 21,983,000 | 25,823,000 | | | Gross Profit | 6,596,000 | 6,516,000 | 6,817,000 | 7,780,000 | | | Operating Expenses | | Research Development | 667,000 | 716,000 | 732,000 | 842,000 | | Selling General and Administrative | 2,874,000 | 2,794,000 | 2,979,000 | 3,451,000 | | Non Recurring | 421,000 | 169,000 | 200,000 | 324,000 | | Others | 379,000 | 380,000 | 412,000 | 337,000 | | | | Total Operating Expenses | 4,341,000 | 4,059,000 | 4,323,000 | 4,954,000 | | | | Operating Income or Loss | 2,255,000 | 2,457,000 | 2,494,000 | 2,826,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 194,000 | (194,000) |
-
| (98,000) | | Earnings Before Interest And Taxes | 2,449,000 | 2,263,000 | 2,494,000 | 2,728,000 | | Interest Expense | 452,000 | 156,000 | 232,000 | 85,000 | | Income Before Tax | 1,997,000 | 2,107,000 | 2,262,000 | 2,643,000 | | Income Tax Expense | 355,000 | 391,000 | 408,000 | 531,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,642,000 | 1,716,000 | 1,854,000 | 2,112,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,642,000 | 1,716,000 | 1,854,000 | 2,112,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,642,000 | $1,716,000 | $1,854,000 | $2,112,000 |
|
0.17% Nasdaq 0.00%
Income Statement
